z-logo
open-access-imgOpen Access
Schistosomiasis haematobium prevalence among haematuric patients: Parasitological and immuno-assay
Author(s) -
Marwa A. Ghieth,
A Lotfy
Publication year - 2017
Publication title -
beni-seuf university journal of basic and applied sciences /beni-suef university journal of basic and applied sciences
Language(s) - English
Resource type - Journals
eISSN - 2314-8543
pISSN - 2314-8535
DOI - 10.1016/j.bjbas.2017.01.007
Subject(s) - schistosoma haematobium , schistosomiasis , dipstick , helminthiasis , immunology , urine , medicine , epidemiology , antibody , schistosoma , parasitic disease , gastroenterology , helminths , disease , schistosoma mansoni
Schistosoma haematobium infection is a clinically important water born parasitic disease. This study was conducted to detect the prevalence of schistosomiasis haematobium among haematuric patients by microscopy and immunoassay. About 474 symptomized patients with urological manifestations and attending Beni-Suef University Hospital, Egypt were subjected to microhaematuria detection using dipstick reagent strip. Positive patients for microhaematuria were subjected to parasitological and immunological assay to detect S. haematobium eggs and antibodies. Haematuria prevalence was 17.7% (n = 84). Egg of S. haematobium wasn’t detected by microscopic examination of urine sediment of all haematuric patients, immunological prevalence of Schistosoma antibodies was 46.4% (n = 39). On comparing seropositive and seronegative patients for schistosomiasis antibodies none of the sociodemographic or clinical data were statistically significant. It was concluded that, negative microscopy for schistosomiasis doesn’t exclude infection. Combination of both clinical and epidemiological data in addition to sensitive diagnostic tools is essential for schistosomiasis. There is a critical need to develop more sensitive method to detect true prevalence of schistosomiasis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here